Prediction of early-stage melanoma recurrence using clinical and histopathologic features
Prognostic analysis for early-stage (stage I/II) melanomas is of paramount importance for customized surveillance and treatment plans. Since immune checkpoint inhibitors have recently been approved for stage IIB and IIC melanomas, prognostic tools to identify patients at high risk of recurrence have...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2022
|
| Sorozat: | NPJ PRECISION ONCOLOGY
6 No. 1 |
| Tárgyszavak: | |
| doi: | 10.1038/s41698-022-00321-4 |
| mtmt: | 33548079 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26531 |